Importance of radiation time and dose factors on outcome for childhood medulloblastoma

Australasian Radiology

Volumn 49, Issue 4, 2005, Pages 298-303

  Back, Michael ^a,c   Ahern, V ^b   Berry, M ^b   Borg, M ^b   Sexton, M ^b   Cameron, F ^b   Stevens, G ^b   Allison, R ^b   Childs, J ^b   Barton, M ^b  

^a NEWCASTLE MATER HOSPITAL   (Australia)

^b LIVERPOOL HOSPITAL   (Australia)

^c NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Medulloblastoma; Radiotherapy; Treatment duration

Indexed keywords

ADOLESCENT; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; POSTERIOR FOSSA; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RETROSPECTIVE STUDY;

ADOLESCENT; CEREBELLAR NEOPLASMS; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CRANIAL FOSSA, POSTERIOR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; MALE; MEDULLOBLASTOMA; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 23244461829     PISSN: 00048461     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1673.2005.01468.x     Document Type: Conference Paper

References (23)

1. Freeman CR, Taylor RE, Kortmann RD, Carrie C. Radiotherapy for medulloblastoma in children: a perspective on current international clinical research efforts. Med Pediatr Oncol 2002; 39: 99-108.
2. Bailey CC, Gnekow A, Wellek S et al. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 1995; 25: 166-78.
3. Thomas PR, Deutsch M, Kepner JL et al. Low-stage medulloblastoma: final analysis of trial comparing standard-dose with reduced-dose neuraxis irradiation. J Clin Oncol 2000; 18: 3004-11.
4. Taylor RE, Bailey CC, Robinson K et al. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. J Clin Oncol 2003; 21: 1581-91.
5. Yao MS, Mehta MP, Boyett JM et al. The effect of M-stage on patterns of failure in posterior fossa primitive neuroectodermal tumors treated on CCG-921: a phase III study in a high-risk patient population. Int J Radiat Oncol Biol Phys 1997; 38: 469-76.
6. Bouffet E, Doz F, Demaille MC et al. Improving survival in recurrent medulloblastoma: earlier detection, better treatment or still an impasse? Br J Cancer 1998; 77: 1321-6.
7. Tait DM, Thornton-Jones H, Bloom HJ et al. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 1990; 26: 464-9.
8. Albright AL, Wisoff JH, Zeltzer PM et al. Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer Group. Neurosurgery 1996; 38: 265-71.
9. Berry MP, Jenkin RD, Keen CW et al. Radiation treatment for medulloblastoma. A 21-year review. J Neurosurg 1981; 55: 43-51.
10. Hoshino T, Nagashima T, Murovic J et al. Cell kinetic studies of in situ human brain tumors with bromodeoxyuridine. Cytometry 1985; 6: 627-32.
11. Ito S, Hoshino T, Prados MD, Edwards MS. Cell kinetics of medulloblastomas. Cancer 1992; 70: 671-8.
12. Withers HR. Treatment induced accelerated human tumor growth. Semin Radiat Oncol 1993; 3: 135-43.
13. Barton MB, Keane TJ, Gadalla T, Maki E. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer. Radiother Oncol 1992; 23: 137-43.
14. Kaplan ES, Meier PJ. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
15. Hartsell WF, Montag AG, Lydon J et al. Treatment of medulloblastoma in adults. Am J Clin Oncol 1992; 15: 207-11.
16. Carrie C, Hoffstetter S, Gomez F et al. Impact of targeting deviations on outcome in medulloblastoma: study of the French Society of Pediatric Oncology (SFOP). Int J Radiat Oncol Biol Phys 1999; 45: 435-9.
17. Fyles A, Keane TJ, Barton M, Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 1992; 25: 273-9.
18. del Charco JO, Bolek TW, McCollough WM et al. Medulloblastoma: time-dose relationship based on a 30-year review. Int J Radiat Oncol Biol Phys 1998; 42: 147-54.
19. Paulino AC, Wen BC, Mayr NA et al. Protracted radiotherapy treatment duration in medulloblastoma. Am J Clin Oncol 2003; 26: 55-9.
20. Chan AW, Tarbell NJ, Black PM et al. Adult medulloblastoma: prognostic factors and patterns of relapse. Neurosurgery 2000; 47: 623-31.
21. Khafaga Y, Kandil AE, Jamshed A et al. Treatment results for 149 medulloblastoma patients from one institution. Int J Radiat Oncol Biol Phys 1996; 35: 501-6.
22. Miralbell R, Bleher A, Huguenin P et al. Pediatric medulloblastoma: radiation treatment technique and patterns of failure. Int J Radiat Oncol Biol Phys 1997; 37: 523-9.
23. Allen JC, Donahue B, DaRosso R, Nirenberg A. Hyperfractionated craniospinal radiotherapy and adjuvant chemotherapy for children with newly diagnosed medulloblastoma and other primitive neuroectodermal tumors. Int J Radiat Oncol Biol Phys 1996; 36: 1155-61.